In vivo Lesion Index (LSI) validation in percutaneous radiofrequency catheter ablation
- Themistoclakis, Sakis
- Calzolari, Vittorio
- De Mattia, Luca
- China, Paolo
- Dello Russo, Antonio
- Fassini, Gaetano
- Casella, Michela
- Caporaso, Igor
- Indiani, Stefano
- Addis, Alessandro
- Basso, Cristina
- Della Barbera, Mila
- Thiene, Gaetano
- Tondo, Claudio
Publication date
January 2022
DOIAbstract
Lesion Index (LSI) has been developed to predict lesion efficacy during radiofrequency (RF) catheter ablation. However, its value in predicting lesions size has still to be established. The aim of our study was to assess the lesions size reproducibility for prespecified values of LSI reached during RF delivery in an in vivo beating heart
Add to ORKG